America’s drug regulator has already approved an orexin agonist for narcolepsy, a disorder that leaves patients excessively sleepy by day and prone to nod off without warning. But hopes for this new drug type do not end there
View on Bluesky
Source: at://did:plc:kkf4naxqmweop7dv4l2iqqf5/app.bsky.feed.generator/news-2-0
Author: The Economist (@economist.com)
View on Bluesky
Source: at://did:plc:kkf4naxqmweop7dv4l2iqqf5/app.bsky.feed.generator/news-2-0
Author: The Economist (@economist.com)